Rankings
▼
Calendar
MAZE Q4 2024 Earnings — Maze Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
MAZE
Maze Therapeutics, Inc.
$2B
Q4 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$30M
Net Income
-$30M
EPS (Diluted)
$-0.11
QoQ Revenue Growth
-100.0%
Cash Flow
Operating Cash Flow
-$22M
Free Cash Flow
-$23M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$241M
Total Liabilities
$44M
Stockholders' Equity
$197M
Cash & Equivalents
$197M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$30M
-$23M
-29.0%
Net Income
-$30M
-$27M
-11.3%
← FY 2024
All Quarters
Q1 2025 →